AKT1 (Ab-308) Antibody

Shipped with Ice Packs
In Stock

Description

AKT1 Structure and Function

AKT1 (also known as RAC-PK-alpha or Protein kinase B) is one of three closely related serine/threonine protein kinases (AKT1, AKT2, and AKT3) that constitute the AKT kinase family . AKT1 plays crucial roles in regulating diverse cellular processes including metabolism, proliferation, cell survival, growth, and angiogenesis . The protein is characterized by specific accession numbers (Swiss-Prot: P31749, NCBI Protein: NP_001014431.1) and gene ID 207 .

Signaling Pathways

AKT1 mediates its effects through serine and/or threonine phosphorylation of numerous downstream substrates . The protein is central to insulin signaling, regulating glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface . Additionally, AKT1 regulates glycogen storage through phosphorylation of GSK3A at 'Ser-21' and GSK3B at 'Ser-9', inhibiting their kinase activity .

Validated Applications

The AKT1 (Ab-308) Antibody has been validated for multiple applications, primarily Western blotting (WB) and immunohistochemistry (IHC) . The recommended dilutions for optimal results are as follows:

ApplicationRecommended Dilution
Western Blotting1:500 - 1:1000
Immunohistochemistry1:50 - 1:100

Research Validation Data

Scientific validation of the AKT1 (Ab-308) Antibody includes Western blot analysis of extracts from HepG2 and HeLa cells, demonstrating specificity for the target protein . These validation studies confirm the antibody's ability to recognize endogenous AKT1 in human cell lines, providing researchers with confidence in experimental applications.

Immunization Protocol

The antibody is produced by immunizing rabbits with a synthetic peptide corresponding to amino acids 306-310 of human AKT1, conjugated to KLH (Keyhole Limpet Hemocyanin) carrier protein . This immunization strategy generates polyclonal antibodies with multiple epitope recognition capabilities, enhancing detection sensitivity.

Purification Process

Following immunization, the antibodies undergo affinity chromatography purification using epitope-specific peptides . This purification process ensures high specificity by selectively isolating antibodies that recognize the target epitope, reducing background signal and cross-reactivity in experimental applications.

Specificity Testing

The AKT1 (Ab-308) Antibody is rigorously tested to confirm its ability to detect endogenous levels of total AKT protein . Quality control measures include Western blot analysis against cell extracts from commonly used cell lines such as HepG2 and HeLa, demonstrating the expected 60 kDa band corresponding to AKT1 .

Cross-Reactivity Assessment

The antibody has confirmed reactivity with human, mouse, and rat samples, making it a versatile tool for comparative studies across these species . This cross-species reactivity facilitates translational research from animal models to human applications.

Recommended Protocols

For Western blotting, optimal results are achieved at dilutions between 1:500 and 1:1000, while immunohistochemistry applications require dilutions of 1:50 to 1:100 . Researchers should optimize specific conditions for their particular experimental systems, considering sample type, antigen abundance, and detection method.

Compatible Secondary Antibodies

The AKT1 (Ab-308) Antibody, being rabbit-derived, is compatible with various anti-rabbit IgG secondary antibodies, including those conjugated to alkaline phosphatase (AP), biotin, fluorescent tags (FITC), or horseradish peroxidase (HRP) . Selection of appropriate secondary antibodies should align with the desired detection method and experimental design.

Product Specs

Form
Supplied at 1.0 mg/mL in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02% sodium azide and 50% glycerol.
Lead Time
Typically, we can ship your orders within 1-3 business days of receipt. Delivery times may vary depending on the purchasing method or location. Please contact your local distributor for specific delivery information.
Synonyms
AKT 1 antibody; AKT antibody; AKT1 antibody; AKT1_HUMAN antibody; C AKT antibody; cAKT antibody; MGC99656 antibody; PKB alpha antibody; PKB antibody; PKB-ALPHA antibody; PRKBA antibody; Protein Kinase B Alpha antibody; Protein kinase B antibody; Proto-oncogene c-Akt antibody; RAC Alpha antibody; RAC antibody; Rac protein kinase alpha antibody; RAC Serine/Threonine Protein Kinase antibody; RAC-alpha serine/threonine-protein kinase antibody; RAC-PK-alpha antibody; v akt murine thymoma viral oncogene homolog 1 antibody; vAKT Murine Thymoma Viral Oncogene Homolog 1 antibody
Target Names
Uniprot No.

Target Background

Function
AKT1 is one of three closely related serine/threonine-protein kinases (AKT1, AKT2, and AKT3) collectively known as the AKT kinase. These kinases play critical roles in regulating various cellular processes, including metabolism, proliferation, cell survival, growth, and angiogenesis. This regulation is achieved through the phosphorylation of a diverse range of downstream substrates, primarily on serine and/or threonine residues. Over 100 potential substrate candidates have been identified, but for most, isoform specificity remains unclear. AKT is responsible for regulating glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface. Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity, preventing dephosphorylation of the insulin receptor and attenuating insulin signaling. Phosphorylation of TBC1D4 triggers its binding to inhibitory 14-3-3 proteins, which is essential for insulin-stimulated glucose transport. AKT also regulates glucose storage in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', inhibiting their kinase activity. The phosphorylation of GSK3 isoforms by AKT is also believed to be a mechanism by which cell proliferation is driven. AKT further regulates cell survival through phosphorylation of MAP3K5 (apoptosis signal-related kinase). Phosphorylation at 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress, thereby preventing apoptosis. AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', activating mTORC1 signaling and leading to both phosphorylation of 4E-BP1 and activation of RPS6KB1. AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to the binding of 14-3-3 proteins and cytoplasmic localization. Specifically, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256', and 'Ser-319'. FOXO3 and FOXO4 are phosphorylated at equivalent sites. AKT plays a crucial role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein). The phosphorylation of CREB1 induces the binding of accessory proteins necessary for the transcription of pro-survival genes such as BCL2 and MCL1. AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), potentially regulating ACLY activity and fatty acid synthesis. AKT activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis. AKT phosphorylates PIKFYVE at 'Ser-318', which increases PI(3)P-5 activity. The Rho GTPase-activating protein DLC1 is another substrate, and its phosphorylation is implicated in the regulation of cell proliferation and growth. AKT acts as a key modulator of the AKT-mTOR signaling pathway, controlling the tempo of newborn neuron integration during adult neurogenesis, including correct neuron positioning, dendritic development, and synapse formation. AKT signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors, such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin, and insulin-like growth factor I (IGF-I). AKT mediates the antiapoptotic effects of IGF-I. AKT is essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly. It may be involved in the regulation of placental development. AKT phosphorylates STK4/MST1 at 'Thr-120' and 'Thr-387', leading to inhibition of its kinase activity, nuclear translocation, autophosphorylation, and ability to phosphorylate FOXO3. AKT phosphorylates STK3/MST2 at 'Thr-117' and 'Thr-384', leading to inhibition of its cleavage, kinase activity, autophosphorylation at Thr-180, binding to RASSF1, and nuclear translocation. AKT phosphorylates SRPK2, enhancing its kinase activity towards SRSF2 and ACIN1 and promoting its nuclear translocation. AKT phosphorylates RAF1 at 'Ser-259' and negatively regulates its activity. Phosphorylation of BAD stimulates its pro-apoptotic activity. AKT phosphorylates KAT6A at 'Thr-369', inhibiting the interaction of KAT6A with PML and negatively regulating its acetylation activity towards p53/TP53. AKT phosphorylates palladin (PALLD), modulating cytoskeletal organization and cell motility. AKT phosphorylates prohibitin (PHB), playing an important role in cell metabolism and proliferation. AKT phosphorylates CDKN1A, for which phosphorylation at 'Thr-145' induces its release from CDK2 and cytoplasmic relocalization. These recent findings indicate that the AKT1 isoform has a more specific role in cell motility and proliferation. AKT phosphorylates CLK2, controlling cell survival to ionizing radiation. AKT phosphorylates PCK1 at 'Ser-90', reducing the binding affinity of PCK1 to oxaloacetate and transforming PCK1 into an atypical protein kinase activity using GTP as a donor. AKT also acts as an activator of TMEM175 potassium channel activity in response to growth factors: it forms the lysoK(GF) complex together with TMEM175 and acts by promoting TMEM175 channel activation, independently of its protein kinase activity.
Gene References Into Functions
  1. A melatonin concentration of 3 mM significantly reduced intracellular reactive oxygen species levels, caspase-3 activity, and the percentage of both dead and apoptotic-like sperm cells. It also increased vitality, progressive motility, total motility, and AKT phosphorylation compared to the control group. PMID: 29196809
  2. The findings suggest that SPRY4 and SPRY4-IT1 may act as oncogenes in testicular germ cell tumors via activation of the PI3K/Akt signaling pathway. PMID: 29410498
  3. The data indicate that transient receptor potential vanilloid 4 (TRPV4) accelerates glioma migration and invasion through the AKT/Rac1 signaling pathway. TRPV4 could be considered a potential target for glioma therapy. PMID: 29928875
  4. The study reveals a regulatory mechanism underlying drug resistance and suggests that tribbles homologue 2 (TRIB2) functions as a regulatory component of the PI3K network, activating AKT in cancer cells. PMID: 28276427
  5. The findings indicate that shikonin inhibits proliferation and promotes apoptosis in human endometrioid endometrial cancer (EEC) cells by modulating the miR-106b/PTEN/AKT/mTOR signaling pathway, suggesting shikonin could be a potential therapeutic agent for EEC treatment. PMID: 29449346
  6. SIRT6 inhibited proliferation, migration, and invasion of colon cancer cells by upregulating PTEN expression and downregulating AKT1 expression. PMID: 29957460
  7. LHPP suppresses cell proliferation and metastasis in cervical cancer and promotes apoptosis by suppressing AKT activation. PMID: 29944886
  8. The data show that activated proto-oncogene protein Akt (AKT) directly phosphorylates Fas associated factor 1 (FAF1), reducing FAF1 at the plasma membrane and resulting in an increase in TGF-beta type II receptor (TbetaRII) at the cell surface. PMID: 28443643
  9. The data show that while overexpression of AKT serine/threonine kinase 1 (AKT1) promoted local tumor growth, downregulation of AKT1 or overexpression of AKT serine/threonine kinase 2 (AKT2) promoted peritumoral invasion and lung metastasis. PMID: 28287129
  10. High AKT1 expression is associated with metastasis in ovarian cancer. PMID: 29739299
  11. Circ-CFH promotes glioma progression by sponging miR-149 and regulating the AKT1 signaling pathway. PMID: 30111766
  12. High AKT1 expression is associated with metastasis via epithelial-mesenchymal transition carcinoma in colorectal cancer. PMID: 30066935
  13. High AKT1 expression is associated with tumor-node-metastasis in non-small cell lung cancer. PMID: 30106450
  14. High expression of AKT1 is associated with drug resistance and proliferation of breast cancer. PMID: 28165066
  15. Germline variants in the AKT1 gene are associated with prostate cancer. PMID: 29298992
  16. High AKT1 expression is associated with cisplatin-resistant oral cancer. PMID: 29956797
  17. Akt1 was identified as a novel target for miR-637. Its knockdown also induced cell growth inhibition and apoptosis in pancreatic ductal adenocarcinoma cells. PMID: 29366808
  18. High AKT1 expression is associated with periodontitis. PMID: 30218719
  19. High AKT1 expression is associated with angiogenesis of esophageal squamous cell carcinoma. PMID: 30015941
  20. High AKT1 expression is associated with Pancreatic Ductal Adenocarcinoma Metastasis. PMID: 29386088
  21. In MCF-7 cells, AIB1 overexpression increases p-AKT (Ser 473) activity. In both T47D and MCF-7 cells overexpressing A1B1, p-AKT (Ser 473) expression was significantly increased in the presence or absence of IGF-1, but increased more in the presence of IGF-1. PMID: 29808803
  22. In this study, the Ion Personal Genome Machine (PGM) and Ion Torrent Ampliseq Cancer panel were used to sequence hotspot regions from PIK3CA, AKT, and PTEN genes to identify genetic mutations in 39 samples of TNBC subtype from Moroccan patients and to correlate the results with clinical-pathologic data. PMID: 30227836
  23. The AKT pathway is activated by CBX8 in hepatocellular carcinoma. PMID: 29066512
  24. The authors identified a direct interaction of both MEK1 and MEK2 with AKT. The interaction between MEK and AKT affects cell migration and adhesion, but not proliferation. The specific mechanism of action of the MEK-AKT complex involves phosphorylation of the migration-related transcription factor FoxO1. PMID: 28225038
  25. miR-195 suppresses cell proliferation of ovarian cancer cells through regulation of VEGFR2 and AKT signaling pathways. PMID: 29845300
  26. High AKT1 expression is associated with cell growth, aggressiveness, and metastasis in gastric cancer. PMID: 30015981
  27. This is the first report showing long-duration exposure to nicotine causes increased proliferation of human kidney epithelial cells through activation of the AKT pathway. PMID: 29396723
  28. RBAP48 overexpression contributes to the radiosensitivity of AGS gastric cancer cells via phosphoinositide3kinase/protein kinase B pathway suppression. PMID: 29901205
  29. Activating Akt1 mutations alter DNA double-strand break repair and radiosensitivity. PMID: 28209968
  30. PI3K-Akt pathway inhibitors, Akti-1/2 and LY294002, reduced PFKFB3 gene induction by PHA, as well as Fru-2,6-P2 and lactate production. Moreover, both inhibitors blocked activation and proliferation in response to PHA, highlighting the importance of the PI3K/Akt signaling pathway in the antigen response of T-lymphocytes. PMID: 29435871
  31. RIO kinase 3 (RIOK3) positively regulates the activity of the AKT/mTOR pathway in glioma cells. PMID: 29233656
  32. High AKT1 phosphorylation is associated with colorectal carcinoma. PMID: 29970694
  33. Results show that AKT1 was associated with hypertension in Mexican Mestizos but not Mexican Amerindians. PMID: 30176313
  34. TERT could induce thyroid carcinoma cell proliferation mainly through the PTEN/AKT signaling pathway. PMID: 29901196
  35. The findings uncover a new function of p53 in the regulation of Akt signaling and reveal how p53, ASS1, and Akt are interrelated. PMID: 28560349
  36. Quantitative mass spectrometry of IAV1918-infected cells was performed to measure host protein dysregulation. Selected proteins were validated by immunoblotting, and phosphorylation levels of members of the PI3K/AKT/mTOR pathway were assessed. PMID: 29866590
  37. Radiation resistance tumors have upregulated Onzin and POU5F1 expression. PMID: 29596836
  38. The essential role of AKT in endocrine therapy resistance in estrogen receptor-positive, HER2-negative breast cancer. [review] PMID: 29086897
  39. FAL1 may work as a ceRNA to modulate AKT1 expression via competitively binding to miR-637 in HSCR. PMID: 30062828
  40. The overexpression of CHIP significantly increased the migration and invasion of the DU145 cells, possibly due to activation of the AKT signaling pathway and upregulation of vimentin. The expression level of CHIP was observed to be increased in human prostate cancer tissues compared to the adjacent normal tissue. PMID: 29693147
  41. Genistein (GE) inhibited the growth of human Cholangiocarcinoma (CCA) cell lines by reducing the activation of EGFR and AKT, and by attenuating the production of IL6. E2 and ER were also involved in the growth-inhibitory effect of GE in CCA cells. PMID: 29693152
  42. This study identifies ORP2 as a new regulatory nexus of Akt signaling, cellular energy metabolism, actin cytoskeletal function, cell migration, and proliferation. PMID: 29947926
  43. The role of USP18 in breast cancer provides a novel insight into the clinical application of the USP18/AKT/Skp2 pathway. PMID: 29749454
  44. Collectively, these results indicate that COX-1/PGE2/EP4 upregulates the beta-arr1-mediated Akt signaling pathway to provide mucosal protection in colitis. PMID: 28432343
  45. The AKT kinase pathway is regulated by SPC24 in breast cancer. PMID: 30180968
  46. CREBRF promotes the proliferation of human gastric cancer cells via the AKT signaling pathway. PMID: 29729692
  47. These results indicate that miR124 transection inhibits the growth and aggressiveness of osteosarcoma, potentially via suppression of TGFbeta-mediated AKT/GSK3beta/snail family transcriptional repressor 1 (SNAIL1) signaling, suggesting miR124 may be a potential anticancer agent/target for osteosarcoma therapy. PMID: 29488603
  48. Piperine reduced the expression of pAkt, MMP9, and pmTOR. Together, these data indicated that piperine may serve as a promising novel therapeutic agent to better overcome prostate cancer metastasis. PMID: 29488612
  49. S100A8 gene knockdown reduced cell proliferation in the HEC-1A cells compared to control cells, induced cell apoptosis, inhibited the phosphorylation of protein kinase B (Akt), and induced the expression of pro-apoptotic genes. PMID: 29595187
  50. Intact keratin filaments are regulators for PKB/Akt and p44/42 activity, both basal and in response to stretch. PMID: 29198699

Show More

Hide All

Database Links

HGNC: 391

OMIM: 114480

KEGG: hsa:207

STRING: 9606.ENSP00000270202

UniGene: Hs.525622

Involvement In Disease
Breast cancer (BC); Colorectal cancer (CRC); Proteus syndrome (PROTEUSS); Cowden syndrome 6 (CWS6)
Protein Families
Protein kinase superfamily, AGC Ser/Thr protein kinase family, RAC subfamily
Subcellular Location
Cytoplasm. Nucleus. Cell membrane.
Tissue Specificity
Expressed in prostate cancer and levels increase from the normal to the malignant state (at protein level). Expressed in all human cell types so far analyzed. The Tyr-176 phosphorylated form shows a significant increase in expression in breast cancers dur

Q&A

What is AKT1 and what cellular functions does it regulate?

AKT1 is one of three closely related serine/threonine-protein kinases (AKT1, AKT2, and AKT3) collectively known as the AKT kinase family. These kinases regulate numerous cellular processes including:

  • Metabolism and glucose homeostasis

  • Cell proliferation and cell cycle progression

  • Cell survival and anti-apoptotic responses

  • Cellular growth and protein synthesis

  • Angiogenesis

AKT1 mediates these functions through serine and/or threonine phosphorylation of over 100 downstream substrate candidates. The protein plays a central role in insulin signaling, glucose metabolism, and cell survival pathways .

What epitope does the AKT1 (Ab-308) Antibody recognize?

The AKT1 (Ab-308) Antibody specifically recognizes a peptide sequence around amino acids 306-310 (M-K-T-F-C) of the human AKT1 protein. This region is located near the T308 phosphorylation site, which is one of the key regulatory sites for AKT1 activation . The antibody is designed to detect AKT1 regardless of its phosphorylation status, making it useful for measuring total AKT1 protein levels .

What is the relationship between the AKT1 T308 phosphorylation site and antibody specificity?

The T308 phosphorylation site of AKT1 is critical for its activation. When developing or selecting antibodies, it's important to understand that:

  • Phospho-specific antibodies (like those against phospho-T308) specifically detect only the phosphorylated form of AKT1

  • The AKT1 (Ab-308) Antibody recognizes a region near but not identical to the T308 phosphorylation site

  • For comprehensive AKT1 signaling studies, researchers often need both total AKT1 antibodies and phospho-specific antibodies to calculate activation ratios

What are the optimal protocols for using AKT1 (Ab-308) Antibody in Western Blot analysis?

For optimal Western Blot results with AKT1 (Ab-308) Antibody:

ParameterRecommendation
Dilution1:500 - 1:1000
Expected Band SizeApproximately 56 kDa
Sample TypesCell lysates (HepG2, HeLa, etc.)
Blocking5% non-fat milk or BSA in TBST
Secondary AntibodyAnti-rabbit IgG conjugated to HRP
Exposure MethodEither chemiluminescence or fluorescence detection

For phosphorylation studies, remember to include phosphatase inhibitors in your lysis buffer to preserve phosphorylation status. Additionally, when studying AKT1 activation, parallel blots with phospho-specific antibodies (pT308, pS473) should be performed to assess activation status .

What are the recommended protocols for immunohistochemistry applications?

For immunohistochemistry applications:

ParameterRecommendation
Dilution1:50 - 1:200
Sample PreparationFresh frozen tissues preferred over paraffin-embedded
Antigen RetrievalCitrate buffer (pH 6.0) heat-induced retrieval
Detection SystemPolymer-based or avidin-biotin detection systems
ControlsInclude positive controls (tissues known to express AKT1) and negative controls

Note: The antibody has been validated for mouse, rat, and human tissues. For other species, preliminary testing is recommended due to the sequence homology (the immunogen shows 85% identity to mouse and 92% identity to rat AKT1) .

How does the phosphorylation cascade regulate AKT1 activity and how can it be monitored?

AKT1 activation involves a multi-step phosphorylation cascade:

  • Initial phosphorylation at Thr450 by JNK kinases

  • Phosphorylation at Thr308 by PDK1 (in the activation loop)

  • Phosphorylation at Ser473 by PDK2 or mTORC2 (in the C-terminal regulatory domain)

To properly monitor this activation cascade:

  • Use phospho-specific antibodies against each site

  • Implement time-course experiments after stimulation

  • Compare phosphorylation patterns across different stimuli

  • Correlate phosphorylation with downstream substrate activation

Research has shown that Thr308 phosphorylation is necessary and sufficient for AKT1 activation, while Ser473 phosphorylation enhances this activity and might direct substrate specificity .

What is the relationship between AKT1 methylation and its phosphorylation/activation?

Recent research has revealed that AKT1 methylation plays a crucial role in its activation:

  • AKT1 is methylated in its linker region by the histone methyltransferase SETDB1

  • This methylation is antagonized by the demethylase KDM4B

  • Methylation promotes the interaction of AKT1 with PDK1, enhancing Thr308 phosphorylation

  • Methylation-deficient AKT1 mutants (K140/142R) show:

    • Reduced interaction with PDK1

    • Diminished binding to PtdIns(3,4,5)P3

    • Decreased association with the cell membrane

This indicates that methylated AKT1 has a greater propensity to bind PtdIns(3,4,5)P3, promoting membrane localization where it can be phosphorylated by PDK1 .

How can I study AKT1's interactome and its cell cycle-dependent interactions?

To study the AKT1 interactome and its cell cycle-dependent associations:

  • Experimental approach: Use affinity purification coupled with mass spectrometry (AP-MS) as demonstrated in studies identifying 213 AKT1 interacting partners

  • Cell cycle synchronization protocols:

    • G0 arrest: Serum starvation (overnight)

    • G1/S arrest: Aphidicolin treatment

    • G2/M arrest: Nocodazole treatment

  • Validation strategies:

    • Co-immunoprecipitation followed by western blot

    • Reverse co-immunoprecipitation

    • siRNA knockdown of interacting partners to assess functional consequences

Studies have shown that 32 proteins exhibit varying association with AKT1 across different cell cycle stages, suggesting stage-specific regulatory mechanisms .

What could cause inconsistent detection of AKT1 using the Ab-308 antibody?

Several factors can contribute to inconsistent AKT1 detection:

IssuePossible CauseSolution
Weak or no signalInsufficient proteinIncrease protein loading or concentrate samples
Inefficient transferOptimize transfer conditions for high MW proteins
Antibody degradationUse fresh aliquots; avoid freeze-thaw cycles
Multiple bandsPost-translational modificationsUse isoform-specific antibodies; include phosphatase treatment
Cross-reactivity with AKT2/3Use AKT1-specific antibodies; validate with knockout controls
Inconsistent results between experimentsVariable activation statesStandardize cell stimulation protocols
Different lysis methodsUse consistent lysis buffers with appropriate inhibitors

Remember that AKT1 expression can be comparable across different cell cycle stages, but its phosphorylation and interaction partners may vary significantly .

How can I distinguish between AKT1, AKT2, and AKT3 in my experiments?

Distinguishing between the three AKT isoforms requires careful experimental design:

  • Antibody selection: Use isoform-specific antibodies that target unique regions

    • AKT1 (Ab-308) targets a sequence specific to AKT1

    • Verify antibody specificity against recombinant AKT isoforms

  • Genetic approaches:

    • siRNA/shRNA knockdown of specific isoforms

    • CRISPR/Cas9-mediated knockout validation

    • Rescue experiments with isoform-specific constructs

  • Expression analysis:

    • RT-qPCR for isoform-specific mRNA expression

    • Tissue/cell-type selection (AKT3 is more restricted to brain tissues)

  • Functional assays:

    • Isoform-specific substrate phosphorylation

    • Cell-based assays exploiting known isoform-specific functions

How can AKT1 (Ab-308) Antibody be used to investigate the role of AKT1 in cell cycle regulation?

Advanced applications for studying AKT1 in cell cycle regulation include:

  • Temporal analysis of AKT1 interactions:

    • Use SILAC (Stable Isotope Labeling with Amino acids in Cell culture) coupled with immunoprecipitation to quantify dynamic changes in AKT1 interactome across cell cycle stages

    • Compare protein associations in G0, G1/S, and G2/M phases

  • Functional validation of interactors:

    • Employ siRNA-mediated silencing of AKT1-interacting proteins

    • Measure effects on population doubling time (PDT)

    • Analyze cell cycle distribution by flow cytometry

  • Pathway integration analysis:

    • Combine AKT1 interactome data with phosphoproteomics

    • Map interactions to known regulatory pathways for protein synthesis and metabolism

Research has shown that AKT1 overexpression decreases population doubling time by approximately 4.92 hours compared to normal cells, confirming its functional role in driving cell cycle progression .

What emerging techniques can be used to study AKT1 phosphorylation dynamics?

Cutting-edge techniques for studying AKT1 phosphorylation dynamics include:

  • Phospho-flow cytometry:

    • Single-cell analysis of phosphorylated AKT1 using fluorescent-conjugated antibodies

    • Allows for heterogeneity assessment within cell populations

    • Can be combined with cell cycle markers for multiparametric analysis

  • Live-cell imaging with phospho-sensors:

    • FRET-based biosensors to monitor AKT1 phosphorylation in real-time

    • Optogenetic tools to induce targeted AKT1 activation

  • Mass spectrometry-based approaches:

    • Targeted quantitative phosphoproteomics

    • Parallel reaction monitoring (PRM) for site-specific phosphorylation quantification

    • Crosslinking mass spectrometry to capture transient interactions

  • Spatial phosphorylation analysis:

    • Super-resolution microscopy to visualize compartmentalized AKT1 activation

    • Proximity ligation assays to detect specific phosphorylated forms in situ

These techniques provide unprecedented insight into the spatial and temporal dynamics of AKT1 phosphorylation and its relationship to cellular function and disease states.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.